Gelonghui November 9th 丨Some investors asked Guanhao Biotech (300238.SZ) on the investor interactive platform, “How is the company's biotype artificial liver research and development progressing?” The company replied that the biological artificial liver project carried out by the company is currently in the scientific research and clinical research stage.
冠昊生物(300238.SZ)：开展的生物人工肝项目，目前处在科研临床研究阶段
Guanhao Biology (300238.SZ): The biological artificial liver project carried out is currently in the scientific research and clinical research stage
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.